Radioimmunoscintigraphy of Gynecologic Tumors with ¹³¹I-Labeled Anti-Plap Monoclonal Antibodies

References

• Andrew S. M., Perkins A. C., Pimm M. V., Baldwin R. W. A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts. Eur. J. Nucl. Med. 1988; 13: 598
   PubMedGoogle Scholar
• Carlsson L., Folkersen J., Stigbrand T. Antigenic determinants of pregnancy associated alpha2-macroglobulin defined by poly- and monoclonal antibodies. Mol. Immunol. 1985; 22: 1073
   Google Scholar
• Carrasquillo J. A., Bunn P. A., Kennan A. M., et al. Radioimmunodetection of cutaneous T-cell lymphoma with 111-In-labelled T101 monoclonal antibody. N. Engl. J. Med. 1986; 315: 673
   PubMed Web of Science ®Google Scholar
• Chatal J. P., Saccavini J. C., Fumoleau P., et al. Immunoscintigraphy of colon carcinoma. J. Nucl. Med. 1984; 25: 307
   PubMed Web of Science ®Google Scholar
• Epenetos A. A., Britton K. E., Mather S. E., et al. Targeting of iodine-123 labelled tumour-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 1982; ii: 999
   Google Scholar
• Epenetos A. A., Snook D., Hooker G., et al. Indium-111 labelled monoclonal antibody to placental alkaline phosphatase in the detection of neoplasms of testis, ovary and cervix. Lancet 1985; ii: 350
   Google Scholar
• Goldenberg D. M., Kim E. E., Bennett S. J., Nelson M. O., de Land F. H. Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms. Gastroenterology 1983; 84: 524
   Google Scholar
• Granowska M., Nimmon C. C., Britton K. E., et al. Kinetic analysis and probability mapping applied to the detection of ovarian cancer by radioimmunoscintigraphy. J. Nucl. Med. 1983; 29: 599
   Google Scholar
• Greenwood F. C., Hunter W. M., Glover J. S. The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 1963; 89: 114
   PubMed Web of Science ®Google Scholar
• Hirano K., Domar U. M., Hajme Y., Brehmer-Andersson E. E., Wahren B. E., Stigbrand T. Levels of alkaline phosphatase isozymes in human seminoma tissue. Cancer Res. 1987; 47: 2543
   PubMedGoogle Scholar
• Jeppsson A., Wahren B., Brehmer-Andersson E., Silverswärd C., Stigbrand T., Millan J. L. Eutopic expression of placental-like alkaline phosphatase in testicular tumours. Int. J. Cancer 1984; 34: 757
   PubMedGoogle Scholar
• Koyama I., Hirano K., Makiya R., Stendahl U., Stigbrand T. Purification and characterization of the placental-like alkaline phosphatase from ovarian epithelial tumours. Br. J. Cancer 1990; 62(Suppl. 10)6
   Google Scholar
• Koyama I., Stendahl U., Stigbrand T. Placental-like alkaline phosphatase from ovary and ascites of a patient with malignant ovarian tumour. Clin. Chim. Acta 1990; 186: 295
   Google Scholar
• Mach J. P., Buchegger F., Forni M., et al. Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol. Today 1981; 2: 239
   PubMedGoogle Scholar
• Malamitsi J., Skarlos D., Fotiou S., et al. Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies. J. Nucl. Med. 1988; 29: 1910
   PubMed Web of Science ®Google Scholar
• Millan J. L., Manes T. Seminoma-derived Nagao isozyme is encoded by a germ-cell alkaline phosphatase gene. Proc. Natl. Acad. Sci. USA 1988; 85: 3024
   PubMed Web of Science ®Google Scholar
• Millan J. L., Stigbrand T. Antigenic determinants of human placental and testicular placental-like alkaline phosphatases as mapped by monoclonal antibodies. Eur. J. Biochem. 1983; 136: 1
   PubMedGoogle Scholar
• Nozawa S., Arai H., Kurihari S. Heat stable alkaline phosphatase in normal uterus and deviation of isozyme profile during uterine carcinogenesis. Human alkaline phosphatases, progress in clinical and biological research, T. Stigbrand, W. H. Fishman. Alan R. Liss Inc., New York 1984; vol. 166: 223
   Google Scholar
• Riklund K. E., Makiya R., Sundström B., et al. Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies. Anticancer Res. 1991, (In press
   Google Scholar
• Cancer markers. Diagnostic and developmental significance, S. Sell. The Human Press, Clifton, NJ 1980
   Google Scholar
• Siccardi A. G., Buraggi G. L., Callegari L., et al. Multicentre study of immunoscintigraphy with radiolabelled monoclonal antibodies in patients with melanoma. Cancer Res. 1986; 46: 4817
   PubMed Web of Science ®Google Scholar
• Stendahl U., Lindgren A., Tholander B., Makiya R., Stigbrand T. Expression of placental alkaline phosphatase in epithelial ovarian tumours. Tumor Biol. 1989; 10: 126
   PubMedGoogle Scholar
• Stigbrand T., Fishman W. Progress in clinical and biological research, W. H. Fishman. Alan R. Liss Inc., New York 1984; vol. 166
   Google Scholar
• Stigbrand T., Hietala S.-O., Johansson B., Makiya R., Riklund K., Ekelund L. Tumour radioimmunolocalization in nude mice by use of antiplacental alkaline phosphatase monoclonal antibodies. Tumour Biol. 1989; 10: 243
   PubMedGoogle Scholar
• Sundström B., Johansson B., Hietala S-O., Stigbrand T. Radioimmunolocalization in nude mice by using anticytokeratin monoclonal antibodies. Tumour Biol. 1990; 11: 158
   PubMedGoogle Scholar
• Sundstöm B. E., Nathrath W. B., Stigbrand T. Diversity in immunoreactivity of tumour derived cytokeratin monoclonal antibodies. J. Histochem. Cytochem. 1989; 37: 1845
   Google Scholar
• Wahren B., Holmgren P.-Å., Stigbrand T. Placental alkaline phosphatase, alphafetoprotein and carcinoembryonic antigen in testicular tumours. Tissue typing by means of cytologic smears. Int. J. Cancer 1979; 24: 749
   PubMed Web of Science ®Google Scholar